Home › Companies › ELEVANCE HEALTH INC. › 2024-2025

ELEVANCE HEALTH INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ELEVANCE HEALTH INC.’s Form 8-K, filed 2025-05-14 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 16Reported items
  • 1,199Asset managers
  • 8,056Fund votes
  • 2025-05-14Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ELEVANCE HEALTH INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ELEVANCE HEALTH INC.

These tallies are ELEVANCE HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ELEVANCE HEALTH INC. — official shareholder meeting results, meeting held 2025-05-14
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Susan D. DeVore 185,839,5863,726,860158,903 --11,942,703 Majority: yes
Elect Director: Bahija Jallal 180,810,8378,752,093162,419 --11,942,703 Majority: yes
Elect Director: Ryan M. Schneider 184,627,2014,951,857146,291 --11,942,703 Majority: yes
Proposal 2: Advisory vote on the Company's executive compensation . 173,964,58015,522,459238,310 --11,942,703 Majority: yes
Proposal 3: Ratification of the appointment of Ernst & Young LLP . 178,086,60723,455,317126,128 ---- Majority: yes
Proposal 4: Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts . 26,240,205160,685,8532,799,291 --11,942,703 Majority: no

Source: ELEVANCE HEALTH INC., Form 8-K, filed with the SEC on 2025-05-14 — read the filing on EDGAR.

How asset managers voted at the ELEVANCE HEALTH INC. 2024-2025 meeting

Each item below shows how the 1,199 asset managers that disclosed a ELEVANCE HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ELEVANCE HEALTH INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote to approve the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 28 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 173,964,580AGAINST: 15,522,459

ELEVANCE HEALTH INC.’s own tally for this item (“Proposal 2: Advisory vote on the Company's executive compensation .”): 173,964,580 for, 15,522,459 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 77% for, 7% against (84% of the company cast a for/against vote).

The 1,173 asset managers below cast 93% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 93%
FOR: 93.3%AGAINST: 6.7%ABSTAIN: 0.0%NOT VOTED: 0.0%A: 0.0%WITHHOLD/ABSTAIN: 0.0%
Largest asset managers voting on “Advisory vote to approve the compensation of our named executive officers.” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard21,475,4412,849 00For
BlackRock16,314,20611,275 00For
T. Rowe Price13,678,92715,546 00For
Capital Group9,317,830100 00For
State Street9,187,602709 00For
Fidelity6,863,3890 00For
Wellington5,251,8670 00For
GEODE CAPITAL MANAGEMENT, LLC5,112,8670 00For
Charles Schwab3,456,7440 00For
Invesco3,457,2060 00For
Artisan3,386,8640 00For
First Eagle Investment Management, LLC2,910,5340 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2,699,0400 00For
Sanders Capital, LLC2,601,4330 00For
Legal & General Investment Management Ltd25,6832,510,722 00Against
FIRST EAGLE FUNDS2,437,3430 00For
John Hancock2,436,2250 00For
Orbis Allan Gray Ltd2,349,4200 00For
Nuveen2,288,0040 00For
Northern Trust2,142,9830 00For
AllianceBernstein1,971,7690 00For
HARRIS ASSOCIATES L P1,900,2100 00For
Grantham, Mayo, Van Otterloo & Co. LLC1,869,6700 00For
MFS1,828,4540 00For
Dimensional1,665,3940 00For

Showing the 25 largest of 1,173 asset managers. See all 1,173 in the interactive database.

2. Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts.

DIVERSITY, EQUITY, AND INCLUSIONMajority of the votes cast: no

Meeting held 2025-05-14.

Combines 9 wordings of this item as funds reported it.

14% Majority: no · of votes cast

FOR 14%AGAINST 86%
FOR: 26,240,205AGAINST: 160,685,853

ELEVANCE HEALTH INC.’s own tally for this item (“Proposal 4: Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts .”): 26,240,205 for, 160,685,853 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 12% for, 71% against (83% of the company cast a for/against vote).

The 213 asset managers below cast 4% of the shares they voted on this item FOR (2,637,794 for, 69,742,671 against).

AGAINST 95%
FOR: 2,637,794 (3.6%)AGAINST: 69,742,671 (94.8%)ABSTAIN: 1,222,526 (1.7%)WITHHOLD/ABSTAIN: 2 (0.0%)
Largest asset managers voting on “Shareholder proposal requesting report on the effectiveness of Diversity, Equity and Inclusion efforts.” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard943,11420,512,477 10Against
BlackRock4,6687,174,664 00Against
Fidelity1,2185,327,988 00Against
T. Rowe Price04,549,698 00Against
Capital Group04,089,010 00Against
State Street4512,437,785 00Against
FIRST EAGLE FUNDS02,437,343 00Against
MFS01,828,454 00Against
Charles Schwab01,712,757 00Against
Invesco01,555,935 00Against
Dimensional01,394,209 00Against
TIAA01,382,693 00Against
HARRIS ASSOCIATES INVESTMENT TRUST01,329,502 00Against
Hartford1981,197,678 00Against
FRANKLIN MUTUAL SERIES FUNDS01,144,770 00Against
Columbia Threadneedle00 1,080,7180Abstain
First Trust0945,280 00Against
John Hancock243,207686,961 00Against
GMO0780,591 00Against
INVESTMENT CO OF AMERICA0566,783 00Against
AMCAP FUND0523,858 00Against
Victory Capital0515,402 00Against
Jackson National0510,835 00Against
Bridge Builder Trust216,956256,845 00Against
JPMorgan47463,244 00Against

Showing the 25 largest of 213 asset managers. See all 213 in the interactive database.

3. To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 8 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 178,086,607AGAINST: 23,455,317

ELEVANCE HEALTH INC.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP .”): 178,086,607 for, 23,455,317 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 79% for, 10% against (89% of the company cast a for/against vote).

The 212 asset managers below cast 98% of the shares they voted on this item FOR (72,029,849 for, 1,422,064 against).

FOR 98%
FOR: 72,029,849 (98.0%)AGAINST: 1,422,064 (1.9%)ABSTAIN: 17,585 (0.0%)WITHHOLD/ABSTAIN: 2 (0.0%)
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025.” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,345,7631,109,829 00For
BlackRock7,179,3320 00For
Fidelity5,329,2060 00For
T. Rowe Price4,549,6980 00For
Capital Group4,089,0100 00For
State Street2,438,20036 00For
FIRST EAGLE FUNDS2,437,3430 00For
MFS1,828,4540 00For
Charles Schwab1,712,7570 00For
Invesco1,555,9350 00For
Dimensional1,394,2090 00For
TIAA1,382,6930 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,329,5020 00For
Hartford1,197,678198 00For
FRANKLIN MUTUAL SERIES FUNDS1,144,7700 00For
Columbia Threadneedle1,080,7180 00For
First Trust945,2800 00For
John Hancock930,1680 00For
GMO780,5910 00For
INVESTMENT CO OF AMERICA566,7830 00For
AMCAP FUND523,8580 00For
Victory Capital515,4020 00For
Jackson National510,8350 00For
Bridge Builder Trust473,8010 00For
JPMorgan463,2910 00For

Showing the 25 largest of 212 asset managers. See all 212 in the interactive database.

4. Election of Directors: Bahija Jallal

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 7 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 180,810,837AGAINST: 8,752,093

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Bahija Jallal”): 180,810,837 for, 8,752,093 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 80% for, 4% against (84% of the company cast a for/against vote).

The 211 asset managers below cast 98% of the shares they voted on this item FOR (71,847,175 for, 1,738,896 against).

FOR 98%
FOR: 71,847,175 (97.6%)AGAINST: 1,738,896 (2.4%)ABSTAIN: 17,588 (0.0%)WITHHOLD/ABSTAIN: 2 (0.0%)
Largest asset managers voting on “Election of Directors: Bahija Jallal” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard21,455,5883 00For
BlackRock7,179,3320 00For
Fidelity5,329,2060 00For
T. Rowe Price4,544,9534,745 00For
Capital Group4,089,0100 00For
State Street2,438,2360 00For
FIRST EAGLE FUNDS2,437,3430 00For
MFS1,828,4540 00For
Charles Schwab1,712,7570 00For
Invesco01,555,935 00Against
Dimensional1,394,2090 00For
TIAA1,382,6930 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,329,5020 00For
Hartford1,197,678198 00For
FRANKLIN MUTUAL SERIES FUNDS1,144,7700 00For
Columbia Threadneedle1,080,7180 00For
First Trust945,2800 00For
John Hancock930,1680 00For
GMO780,5910 00For
INVESTMENT CO OF AMERICA566,7830 00For
AMCAP FUND523,8580 00For
Victory Capital515,4020 00For
Jackson National510,8350 00For
Bridge Builder Trust473,8010 00For
JPMorgan463,2910 00For

Showing the 25 largest of 211 asset managers. See all 211 in the interactive database.

5. Election of Directors: Ryan M. Schneider

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 8 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 184,627,201AGAINST: 4,951,857

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Ryan M. Schneider”): 184,627,201 for, 4,951,857 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 82% for, 2% against (84% of the company cast a for/against vote).

The 211 asset managers below cast 99.9% of the shares they voted on this item FOR (73,533,509 for, 52,562 against).

FOR 99.9%
FOR: 73,533,509 (99.9%)AGAINST: 52,562 (0.1%)ABSTAIN: 17,587 (0.0%)WITHHOLD/ABSTAIN: 2 (0.0%)
Largest asset managers voting on “Election of Directors: Ryan M. Schneider” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard21,455,5902 00For
BlackRock7,179,3320 00For
Fidelity5,329,2060 00For
T. Rowe Price4,544,9534,745 00For
Capital Group4,089,0100 00For
State Street2,438,2360 00For
FIRST EAGLE FUNDS2,437,3430 00For
MFS1,828,4540 00For
Charles Schwab1,712,7570 00For
Invesco1,555,9350 00For
Dimensional1,394,2090 00For
TIAA1,382,6930 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,329,5020 00For
Hartford1,197,8760 00For
FRANKLIN MUTUAL SERIES FUNDS1,144,7700 00For
Columbia Threadneedle1,080,7180 00For
First Trust945,2800 00For
John Hancock930,1680 00For
GMO780,5910 00For
INVESTMENT CO OF AMERICA566,7830 00For
AMCAP FUND523,8580 00For
Victory Capital515,4020 00For
Jackson National510,8350 00For
Bridge Builder Trust473,8010 00For
JPMorgan463,2910 00For

Showing the 25 largest of 211 asset managers. See all 211 in the interactive database.

6. Election of Directors: Susan D. DeVore

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 9 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 185,839,586AGAINST: 3,726,860

ELEVANCE HEALTH INC.’s own tally for this item (“Elect Director: Susan D. DeVore”): 185,839,586 for, 3,726,860 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 82% for, 2% against (84% of the company cast a for/against vote).

The 211 asset managers below cast 97% of the shares they voted on this item FOR (71,456,325 for, 2,124,284 against).

FOR 97%
FOR: 71,456,325 (97.1%)AGAINST: 2,124,284 (2.9%)ABSTAIN: 23,050 (0.0%)WITHHOLD/ABSTAIN: 2 (0.0%)
Largest asset managers voting on “Election of Directors: Susan D. DeVore” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard21,455,5902 00For
BlackRock7,179,3320 00For
Fidelity5,329,2060 00For
T. Rowe Price4,546,4513,247 00For
Capital Group4,089,0100 00For
State Street2,438,2360 00For
FIRST EAGLE FUNDS2,437,3430 00For
MFS01,828,454 00Against
Charles Schwab1,712,7570 00For
Invesco1,555,9350 00For
Dimensional1,394,2090 00For
TIAA1,382,6930 00For
HARRIS ASSOCIATES INVESTMENT TRUST1,329,5020 00For
Hartford1,197,8760 00For
FRANKLIN MUTUAL SERIES FUNDS1,144,7700 00For
Columbia Threadneedle1,080,7180 00For
First Trust945,2800 00For
John Hancock930,1680 00For
GMO780,5910 00For
INVESTMENT CO OF AMERICA566,7830 00For
AMCAP FUND523,8580 00For
Victory Capital515,4020 00For
Jackson National510,8350 00For
Bridge Builder Trust473,8010 00For
JPMorgan463,2910 00For

Showing the 25 largest of 211 asset managers. See all 211 in the interactive database.

7. Ratify Appointment of Independent Auditors

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-14.

Combines 2 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 178,086,607AGAINST: 23,455,317

ELEVANCE HEALTH INC.’s own tally for this item (“Proposal 3: Ratification of the appointment of Ernst & Young LLP .”): 178,086,607 for, 23,455,317 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 79% for, 10% against (89% of the company cast a for/against vote).

The 10 asset managers below cast 23% of the shares they voted on this item FOR (38,914 for, 126,779 against).

FOR 23%AGAINST 77%
FOR: 38,914 (23.5%)AGAINST: 126,779 (76.5%)
Largest asset managers voting on “Ratify Appointment of Independent Auditors” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Cardano Risk Management B.V.0126,779 00Against
Grafton Street Partners Fund, LP31,2150 00For
AMERICAN BEACON FUNDS6,1400 00For
Northern Lights Fund Trust IV8710 00For
PACE SELECT ADVISORS TRUST2760 00For
NORTHERN LIGHTS FUND TRUST III2520 00For
MARCO INVESTMENT MANAGEMENT LLC1000 00For
Simplify Exchange Traded Funds480 00For
ESL Trust Services, LLC80 00For
VOISARD ASSET MANAGEMENT GROUP, INC.40 00For

8. Advisory vote to approve the compensation of our named executive officers

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-15 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 4 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 179,754,212AGAINST: 15,863,613

ELEVANCE HEALTH INC.’s own tally for this item (“Proposal 2: Advisory vote on the Company's executive compensation .”): 179,754,212 for, 15,863,613 against, per its Form 8-K filed 2024-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 80% for, 7% against (87% of the company cast a for/against vote).

The 7 asset managers below cast 100% of the shares they voted on this item FOR (2,130 for, 0 against).

FOR 100%
FOR: 2,130 (100.0%)
Largest asset managers voting on “Advisory vote to approve the compensation of our named executive officers” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC1,6540 00For
Axiom Financial Strategies, LLC2050 00For
VAUGHAN DAVID INVESTMENTS LLC/IL1850 00For
Cox Capital Mgt LLC640 00For
Sky Investment Group LLC220 00For
Echo45 Advisors LLC00 00--
Synergy Investment Management, LLC00 00--

9. S/H Proposal - Create a Non-Discriminatory Sexual Orientation Policy

SHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2025-05-14.

Combines 2 wordings of this item as funds reported it.

30% fund support · no official result

FOR 30%AGAINST 70%

The 4 asset managers below cast 30% of the shares they voted on this item FOR (48 for, 112 against).

FOR: 48 (30.0%)AGAINST: 112 (70.0%)
Largest asset managers voting on “S/H Proposal - Create a Non-Discriminatory Sexual Orientation Policy” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
MARCO INVESTMENT MANAGEMENT LLC0100 00Against
Simplify Exchange Traded Funds480 00For
ESL Trust Services, LLC08 00Against
VOISARD ASSET MANAGEMENT GROUP, INC.04 00Against

10. Election of Directors (Majority Voting)

DIRECTOR ELECTIONS

Meeting held 2025-05-14.

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%
Largest asset managers voting on “Election of Directors (Majority Voting)” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Simplify Exchange Traded Funds480 00For
ESL Trust Services, LLC80 00For
VOISARD ASSET MANAGEMENT GROUP, INC.40 00For

11. Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-14.

92% Majority: yes · of votes cast

FOR 92%8%
FOR: 173,964,580AGAINST: 15,522,459

ELEVANCE HEALTH INC.’s own tally for this item (“Proposal 2: Advisory vote on the Company's executive compensation .”): 173,964,580 for, 15,522,459 against, per its Form 8-K filed 2025-05-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 225,641,361 outstanding shares: 77% for, 7% against (84% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (324 for, 0 against).

FOR 100%
FOR: 324 (100.0%)
Largest asset managers voting on “Compensation” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Members Trust Co2260 00For
Two Roads Shared Trust850 00For
Blue Sky Capital Consultants Group, Inc.130 00For

12. Audit Related

AUDIT-RELATED

Meeting held 2025-05-14.

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (311 for, 0 against).

FOR: 311 (100.0%)
Largest asset managers voting on “Audit Related” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Members Trust Co2260 00For
Two Roads Shared Trust850 00For

13. Director Elections

DIRECTOR ELECTIONS

Meeting held 2025-05-14.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (231 for, 0 against).

FOR: 231 (100.0%)
Largest asset managers voting on “Director Elections” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Members Trust Co2260 00For
Ballew Advisors, Inc50 00For

14. Elect Director

DIRECTOR ELECTIONS

Meeting held 2025-05-14.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (31,467 for, 0 against).

FOR: 31,467 (100.0%)
Largest asset managers voting on “Elect Director” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Grafton Street Partners Fund, LP31,2150 00For
NORTHERN LIGHTS FUND TRUST III2520 00For

15. Report on EEO

DIRECTOR ELECTIONS

Meeting held 2025-05-14.

0% fund support · no official result

AGAINST 100%

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 31,467 against).

AGAINST: 31,467 (100.0%)
Largest asset managers voting on “Report on EEO” at ELEVANCE HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Grafton Street Partners Fund, LP031,215 00Against
NORTHERN LIGHTS FUND TRUST III0252 00Against

Showing the 15 reported items with the widest manager coverage, of 16 in total. View every item.

Largest ELEVANCE HEALTH INC. shareholders voting in 2024-2025

Ranked by the number of ELEVANCE HEALTH INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 225,641,361 shares outstanding at the time of that meeting.

Top ELEVANCE HEALTH INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 9.52%
2BlackRock 7.24%
3T. Rowe Price 6.07%
4Capital Group 4.13%
5State Street 4.07%
6Fidelity 3.04%
7Wellington 2.33%
8GEODE CAPITAL MANAGEMENT, LLC 2.27%
9Charles Schwab 1.54%
10Invesco 1.53%

Reported ELEVANCE HEALTH INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ELEVANCE HEALTH INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 9.44% 13F
State Street 4.72% 13F
T. Rowe Price 4.05% 13F
Wellington Management 2.57% 13F
Morgan Stanley 1.32% 13F
Norges Bank 1.21% 13F
Northern Trust 1.08% 13F

Percentages above are of 225,641,361 shares outstanding, as reported by ELEVANCE HEALTH INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ELEVANCE HEALTH INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ELEVANCE HEALTH INC.'s shareholder meeting held 2025-05-14, in the 2024-2025 proxy season, 1,199 asset managers reported how they voted in their SEC Form N-PX filings, covering 8,056 separate fund positions. Their filings are grouped here into 16 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote to approve the compensation of our named executive officers. — FOR was 92% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ELEVANCE HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-14.

ELEVANCE HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.